TRi-1
TRi-1 is a potent, specific and irreversible inhibitor of cytosolic thioredoxin reductase 1 (TXNRD1), with an IC50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy[1].
Product Specifications
CAS Number
246020-68-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tri-1.html
Concentration
10mM
Purity
99.91
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=[N+](C1=CC=C(OC)N=C1S(=O)(C2=CC=C(Cl)C=C2)=O)[O-]
Molecular Formula
C12H9ClN2O5S
Molecular Weight
328.73
Precautions
H302, H315, H319, H335
References & Citations
[1]Stafford WC, et al. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci Transl Med. 2018 Feb 14;10 (428) . pii: eaaf7444.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15302075 1 Vial
Lentiviral mouse Spint1 shRNA (UAS) - Lentiviral mouseSpint1 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 
MBS1031705-01 0.02 mg (E-Coli)
Recombinant Bacillus anthracis Probable spore germination protein gerPF (gerPF)
Sign In for Pricing
View Details MBS1031705-02 0.1 mg (E-Coli)
Recombinant Bacillus anthracis Probable spore germination protein gerPF (gerPF)
Sign In for Pricing
View Details